Clarity Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,800
Closed -$692K 126
2024
Q1
$692K Buy
+3,800
New +$655K 0.1% 62

Other funds holding ABBV

Clarity Financial's ABBV Position: Q2 2026 in Review

Clarity Financial increased its AbbVie (ABBV) stake by 8.8% in Q2 2026, buying an estimated $3.46M and bringing the position to 198,762 shares worth $50M. The position accounts for 4.25% of the portfolio, ranked #5.

Clarity Financial first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Clarity Financial held 198,762 shares of AbbVie worth $50M as of Q2 2026.
  • Clarity Financial bought 16,086 AbbVie shares in Q2 2026, an estimated $3.46M.
  • AbbVie made up 4.25% of Clarity Financial's portfolio in Q2 2026, its #5 holding.
  • Clarity Financial first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Clarity Financial's 13F filing for Q2 2026, filed 20 Jul 2026.